These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31683699)

  • 1. Synthesis, Antitumor Activity, and Docking Analysis of New Pyrido[3',2':4,5]furo(thieno)[3,2-
    Sirakanyan SN; Spinelli D; Geronikaki A; Hakobyan EK; Sahakyan H; Arabyan E; Zakaryan H; Nersesyan LE; Aharonyan AS; Danielyan IS; Muradyan RE; Hovakimyan AA
    Molecules; 2019 Oct; 24(21):. PubMed ID: 31683699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Evaluation of Antimicrobial Activity and Molecular Dock - ing of New N-1,3-thiazol-2-ylacetamides of Condensed Pyrido[3',2':4,5] furo(thieno)[3,2-d]pyrimidines.
    Sirakanyan SN; Kartsev VG; Geronikaki A; Spinelli D; Petrou A; Hakobyan EK; Glamoclija J; Ivanov M; Sokovic M; Hovakimyan AA
    Curr Top Med Chem; 2020; 20(24):2192-2209. PubMed ID: 32598259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of novel hetero ring fused pyridine derivatives; Their anticancer activity, CoMFA and CoMSIA studies.
    Santhosh Kumar G; Poornachandra Y; Kumar Gunda S; Ratnakar Reddy K; Mohmed J; Shaik K; Ganesh Kumar C; Narsaiah B
    Bioorg Med Chem Lett; 2018 Jul; 28(13):2328-2337. PubMed ID: 29798826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of novel trifluoromethyl substituted furo[2,3-b]pyridine and pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as potential anticancer agents.
    Naresh Kumar R; Poornachandra Y; Nagender P; Mallareddy G; Ravi Kumar N; Ranjithreddy P; Ganesh Kumar C; Narsaiah B
    Eur J Med Chem; 2016 Jan; 108():68-78. PubMed ID: 26629861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Neurotropic Activity and Molecular Docking Study of New Derivatives of pyrano[4″,3″:4',5']pyrido[3',2':4,5]thieno[3,2-
    Dashyan SS; Babaev EV; Paronikyan EG; Ayvazyan AG; Paronikyan RG; Hunanyan LS
    Molecules; 2022 May; 27(11):. PubMed ID: 35684318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico Design, Synthesis and Biological Evaluation of Novel Thieno[3,2-d]pyrimidine Derivatives for Cancer Therapy - A Preliminary Study on the Inhibitory Potential towards ATR Kinase Domain and PIKK Family.
    Sirakanyan SN; Dilip H; Geronikaki A; Spinelli D; Kirubakaran S; Petrou A; Hakobyan EK; Kartsev VG; Paronikyan EG; Yegoryan HA; Yermalovyan LV; Hovakimyan AA
    Chem Biodivers; 2024 Mar; 21(3):e202302071. PubMed ID: 38230843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of antitumor activity of new 4-substituted thieno[3,2-d]pyrimidine and thienotriazolopyrimidine derivatives.
    Hafez HN; El-Gazzar ABA
    Acta Pharm; 2017 Dec; 67(4):527-542. PubMed ID: 29337675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel PI3 kinase p110alpha inhibitors.
    Hayakawa M; Kaizawa H; Moritomo H; Koizumi T; Ohishi T; Yamano M; Okada M; Ohta M; Tsukamoto S; Raynaud FI; Workman P; Waterfield MD; Parker P
    Bioorg Med Chem Lett; 2007 May; 17(9):2438-42. PubMed ID: 17339109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of novel 7-substituted pyrido[2',3':4,5]furo[3,2-d]pyrimidin-4-amines and their N-aryl analogues and evaluation of their inhibitory activity against Ser/Thr kinases.
    Deau E; Loidreau Y; Marchand P; Nourrisson MR; Loaëc N; Meijer L; Levacher V; Besson T
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6784-8. PubMed ID: 24176400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and molecular modelling studies of 8-arylpyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4-amines as multitarget Ser/Thr kinases inhibitors.
    Loidreau Y; Deau E; Marchand P; Nourrisson MR; Logé C; Coadou G; Loaëc N; Meijer L; Besson T
    Eur J Med Chem; 2015 Mar; 92():124-34. PubMed ID: 25549552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of novel spiro[pyrazolo[4,3-d]pyrimidinones and spiro[benzo[4,5]thieno[2,3-d]pyrimidine-2,3'-indoline]-2',4(3H)-diones and their evaluation for anticancer activity.
    Ismail ; Kuthati B; Thalari G; Bommarapu V; Mulakayala C; Chitta SK; Mulakayala N
    Bioorg Med Chem Lett; 2017 Mar; 27(6):1446-1450. PubMed ID: 28216402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiallergy activity of 10-oxo-10H-pyrido[1,2-a]thieno[3,2-d]pyrimidines and 10-oxo-10H-pyrido[1,2-a]thieno[3,4-d]pyrimidines.
    Connor DT; Sorenson RJ; Cetenko WA; Kerbleski JJ; Tinney FJ
    J Med Chem; 1984 Apr; 27(4):528-30. PubMed ID: 6142956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reactions of 4-oxo-4H-pyrido(3',2':4,5)thieno(3,2-d)-1,3-oxazines with amines].
    Böhm N; Krasselt U; Leistner S; Wagner G
    Pharmazie; 1992 Dec; 47(12):897-901. PubMed ID: 1293611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of N-aryl-7-methoxybenzo[b]furo[3,2-d]pyrimidin-4-amines and their N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amine analogues as dual inhibitors of CLK1 and DYRK1A kinases.
    Loidreau Y; Marchand P; Dubouilh-Benard C; Nourrisson MR; Duflos M; Loaëc N; Meijer L; Besson T
    Eur J Med Chem; 2013 Jan; 59():283-95. PubMed ID: 23237976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synthesis of thieno(2,3-b)pyridines with oxalamidic acid or an oxalamidic alkylester residues and of 4-alkoxy-pyrido(3',2':4,5)thieno(3,2-d)pyridine-2-carboxylic acid derivates].
    Wagner G; Leistner S; Vieweg H; Krasselt U; Prantz J
    Pharmazie; 1993 May; 48(5):342-6. PubMed ID: 8327562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antitumor activity of pyrido [2,3-d]pyrimidine and pyrido[2,3-d] [1,2,4]triazolo[4,3-a]pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest.
    Fares M; Abou-Seri SM; Abdel-Aziz HA; Abbas SE; Youssef MM; Eladwy RA
    Eur J Med Chem; 2014 Aug; 83():155-66. PubMed ID: 24956552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chiral 6-aryl-furo[2,3-d]pyrimidin-4-amines as EGFR inhibitors.
    Han J; Kaspersen SJ; Nervik S; Nørsett KG; Sundby E; Hoff BH
    Eur J Med Chem; 2016 Aug; 119():278-99. PubMed ID: 27235841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrido[2, 3-d]pyrimidines and pyrimido[5',4':5, 6]pyrido[2, 3-d]pyrimidines as new antiviral agents: synthesis and biological activity.
    Nasr MN; Gineinah MM
    Arch Pharm (Weinheim); 2002 Jun; 335(6):289-95. PubMed ID: 12210772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel pyrimidine-2,4-dione-1,2,3-triazole and furo[2,3-d]pyrimidine-2-one-1,2,3-triazole hybrids as potential anti-cancer agents: Synthesis, computational and X-ray analysis and biological evaluation.
    Gregorić T; Sedić M; Grbčić P; Tomljenović Paravić A; Kraljević Pavelić S; Cetina M; Vianello R; Raić-Malić S
    Eur J Med Chem; 2017 Jan; 125():1247-1267. PubMed ID: 27875779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antimicrobial activity of some new substituted pyrido[3',2':4,5]thieno[3,2-d]-pyrimidinone derivatives.
    Fayed AA; Amr Ael-G; Al-Omar MA; Mostafa EE
    Bioorg Khim; 2014; 40(3):335-40. PubMed ID: 25898741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.